ValGenesis Announces Strategic Partnership with VTI Life Sciences

ValGenesis Inc., a global developer of Enterprise Validation Lifecycle Management Solutions (VLMS) has formed a strategic partnership with VTI Life Sciences (VTI). The partnership enables VTI to provide clients with validation services using the latest technology available in the ValGenesis VLMS system. As a partner, VTI will provide clients with efficient and cost-effective validation services using ValGenesis VLMS. VTI will also be a marketing partner for the ValGenesis VLMS system.
 
The partnership between ValGenesis and VTI creates a fully comprehensive and innovative approach towards providing validation services using an integrated paperless validation lifecycle management platform. Life science companies will benefit greatly from VTI’s validation expertise and their knowledge of the ValGenesis VLMS platform.
 
“We are pleased to be a strategic technology partner with VTI and look forward to enhanced efficiency, enabled compliance and reduced costs of Validation lifecycle processes through ValGenesis VLMS,” said Siva Samy, CEO of ValGenesis. “We share the same vision, which is providing customers with validation services through VLMS so as to satisfy their every need.”
 
ValGenesis is a comprehensive leading paperless validation lifecycle management solution in the life science industry that allows customers to fully automate the validation process, eliminate inefficiencies found in paper based manual processes, while also reducing costs and validation cycle times. The ValGenesis Validation Lifecycle Management System (VLMS) effectively manages all types of validation activities such as equipment, instruments, computer systems, cleaning, analytical methods, and process validation. ValGenesis’ VLMS covers the entire validation lifecycle thereby delivering technology solutions that are validated, fully configurable and rapidly deployable through onsite or by way of a validated secured cloud environment.

“VTI looks forward to the partnership with ValGenesis and the team of technology experts that ValGenesis represents. Together, VTI and ValGenesis look to providing industry leading, turn-key VLMS integration and support to our customers. We look forward to better serving our clients through this partnership,” VTI President Herb Matheson added.
 
ValGenesis Inc. is the creator of a software platform serving as the foundation for managing compliance-based validation activities in life sciences companies. ValGenesis provides the first enterprise application to manage the corporate validation lifecycle process. As the only system for managing validation execution and approval 100 percent electronically, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award. The solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements.
 
VTI Life Sciences, an ISO 9001:2008 certified company, provides validation, commissioning, and qualification services to the pharmaceutical, biotechnology, biologics, medical device and U.S. Food and Drug Administration (FDA)/internationally-regulated industries. Founded in 1996, VTI offers a range of validation and quality system services for a cGMP/GLP facility. VTI validation professionals have hands-on experience and subject matter expertise in facility design and construction, utility systems, process equipment, process qualification, and computerized systems validation. VTI offers services such as computer validation, cleaning validation, process validation, clean room certification, temperature mapping, process equipment, facility qualification, and more. VTI offices are located in San Diego, Calif.; San Francisco, Calif.; Boston, Mass.; and China.